FDA Civil Monetary Penalties For Human Subject Protection Sought By HHS
This article was originally published in The Gray Sheet
Executive Summary
HHS plans to submit a legislative proposal to Congress by year-end that would authorize FDA to levy civil monetary penalties for infractions of human research subject protections rules, the Clinton administration announced May 23.